High dose of quadrivalent VLP vaccine

BIOLOGICAL2 trials

Sponsors

Medicago

Conditions

RNA Virus InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsVirus Diseases

Phase 1

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

CompletedNCT01991587

MedicagoRespiratory Tract Diseases, Respiratory Tract Infections, RNA Virus Infections +1

Start: 2013-10-08End: 2014-06-30Updated: 2020-06-11

Phase 2

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

CompletedNCT02233816

MedicagoRespiratory Tract Diseases, Respiratory Tract Infections, RNA Virus Infections +1

Start: 2014-07-28End: 2015-06-22Updated: 2019-11-13

Related Papers

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

2019-06-0585 citations